Abstract Purpose of Review Our goal is to examine the processes—both central and
peripheral—that underlie the development of peripherally-induced neuropathic pain (pNP) …

Objective The dorsal root ganglion (DRG) is a novel target for neuromodulation, and DRG
stimulation is proving to be a viable option in the treatment of chronic intractable neuropathic …

Following amputation, most amputees still report feeling the missing limb and often describe
these feelings as excruciatingly painful. Phantom limb sensations (PLS) are useful while …

Introduction The Neuromodulation Appropriateness Consensus Committee (NACC) is
dedicated to improving the safety and efficacy of neuromodulation and thus improving the …

Neuropathic pain is a complex, heterogeneous disorder that affects approximately 8% of the
total adult human population and comes with significant burden for both the patient and …

One innovation currently influencing physical medicine and rehabilitation is brain–computer
interface (BCI) technology. BCI systems used for motor control record neural activity …

The field of neuromodulation has seen unprecedented growth over the course of the last
decade with novel waveforms, hardware advancements, and novel chronic pain indications …

With continued innovations in neuromodulation comes the need for evolving reviews of best
practices. Dorsal root ganglion stimulation (DRG-S) has significantly improved the treatment …

Neurotechnologies for treating pain rely on electrical stimulation of the central or peripheral
nervous system to disrupt or block pain signaling and have been commercialized to treat a …

Objective Dorsal root ganglion stimulation (DRGS) received its first regulatory approval (CE
marking in Europe) in late 2011, and so its use is now almost six years old. Several …